Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17239684 | 0.91 | TSHR (0.37) | ACHETDP1TSHRCES2CES1 | |
| SCHEMBL2557952 | 0.88 | — | — | |
| SCHEMBL30093072 | 0.80 | KIF11 (0.32) | — | |
| SCHEMBL2550429 | 0.78 | LMNA (0.44) | TDP1TSHRLMNANPSR1HPGD | |
| SCHEMBL18650061 | 0.78 | ACHE (0.44) | ACHETDP1TSHRALDH1A1CA2 | |
| SCHEMBL3833780 | 0.76 | ESR1 (0.46) | ACHETSHRALDH1A1CA2CA1 | |
| SCHEMBL2548631 | 0.76 | TSHR (0.48) | ACHETDP1TSHRALDH1A1CA2 | |
| SCHEMBL2546780 | 0.76 | CYP2A6 (0.42) | TDP1ALDH1A1HTTHPGDMEN1 | |
| SCHEMBL16866207 | 0.76 | MAPT (0.42) | ACHETDP1TSHRALDH1A1HPGD | |
| SCHEMBL2550793 | 0.76 | ACHE (0.39) | ACHEALDH1A1CA2CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3024836-B1 | IMPROVED METHOD FOR THE PREPARATION OF CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AG (DE) | 2018-07-11 | — | — | EP | claimed |
| US-20180093942-A1 | PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-04-05 | — | — | US | claimed |
| US-9868694-B2 | Process for preparing chlorinated biphenylanilides and biphenylanilines | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-01-16 | — | — | US | claimed |
| US-20160280635-A1 | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-09-29 | — | — | US | claimed |
| US-12213376-B2 | Organic photoelectric conversion material | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-01-28 | — | — | US | disclosed |
| CN-114270556-B | Organic photoelectric conversion material | 住友化学株式会社 | 2024-03-29 | — | — | CN | disclosed |
| US-20220310939-A1 | ORGANIC PHOTOELECTRIC CONVERSION MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-09-29 | — | — | US | disclosed |
| EP-4024486-A1 | ORGANIC PHOTOELECTRIC CONVERSION MATERIAL | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2022-07-06 | — | — | EP | disclosed |
| CN-110741028-B | Method for producing polymer compound | 住友化学株式会社 | 2022-05-03 | — | — | CN | disclosed |
| CN-110003271-B | Process for producing aromatic compound | 住友化学株式会社 | 2022-05-03 | — | — | CN | disclosed |
| EP-3418284-A1 | IMPROVED METHOD FOR THE PREPARATION OF CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | Bayer CropScience Aktiengesellschaft (DE) | 2018-12-26 | — | — | EP | disclosed |
| EP-3024836-B1 | IMPROVED METHOD FOR THE PREPARATION OF CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AG (DE) | 2018-07-11 | — | — | EP | disclosed |
| US-20130012725-A1 | PROCESS FOR THE REDUCTION OF A TERTIARY PHOSPHINE OXIDE TO THE CORRESPONDING TERTIARY PHOSPHINE IN THE PRESENCE OF A CATALYST AND USE OF A TERTIARY PHOSPHINE FOR REDUCING A TERTIARY PHOSPHINE OXIDE IN THE PRESENCE OF A CATALYST | CHROMAFORA AB (SE) | 2013-01-10 | — | — | US | disclosed |
| WO-2011123037-A1 | A PROCESS FOR THE REDUCTION OF A TERTIARY PHOSPHINE OXIDE TO THE CORRESPONDING TERTIARY PHOSPHINE IN THE PRESENCE OF A CATALYST AND USE OF A TERTIARY PHOSPHINE FOR REDUCING A TERTIARY PHOSPHINE OXIDE IN THE PRESENCE OF A CATALYST | CHROMAFORA AB (SE) | 2011-10-06 | — | — | WO | disclosed |
| US-7847126-B2 | prepared by reacting phosphorus halide with organomagnesium compound in presence of copper compound; di(tert-butyl)phenylphosphonium tetrafluoroborate, for example | LANXESS DEUTSCHLAND GMBH (DE) | 2010-12-07 | — | — | US | disclosed |
| EP-1354886-B1 | Process for the preparation of tertiary phosphines | SALTIGO GMBH (DE) | 2009-08-26 | — | — | EP | disclosed |
| US-20070299273-A1 | prepared by reacting phosphorus halide with organomagnesium compound in presence of copper compound; di(tert-butyl)phenylphosphonium tetrafluoroborate, for example | LANXESS DEUTSCHLAND GMBH (DE) | 2007-12-27 | — | — | US | disclosed |
| US-7230136-B2 | Reacting phosphorus halide with organomagnesium compound in presence of copper compound | LANXESS DEUTSCHLAND GMBH (DE) | 2007-06-12 | — | — | US | disclosed |
| US-20030229240-A1 | Reacting phosphorus halide with organomagnesium compound in presence of copper compound | LANXESS DEUTSCHLAND GMBH (DE) | 2003-12-11 | — | — | US | disclosed |
| EP-1354886-A1 | Process for the preparation of tertiary phosphines | Bayer Aktiengesellschaft (DE) | 2003-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180093942-A1 | PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | DDT, CBR3, MSRB3 | ACHE 1349/4885TDP1 4011/4885TSHR 84/4885 |
| US-20160280635-A1 | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | CYP2F1, CYP1A1, CYP4F12 | ACHE 717/4885TDP1 3383/4885TSHR 661/4885 |
| US-20130012725-A1 | PROCESS FOR THE REDUCTION OF A TERTIARY PHOSPHINE OXIDE TO THE CORRESPONDING TERTIARY PHOSPHINE IN THE PRESENCE OF A CATALYST AND USE OF A TERTIARY PHOSPHINE FOR REDUCING A TERTIARY PHOSPHINE OXIDE IN THE PRESENCE OF A CATALYST | PSPH, PNPO, PHOSPHO1 | ACHE 154/4885TDP1 1944/4885TSHR 1485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.